Different Involvement of OAT in Renal Disposition of Oral Anticoagulants Rivaroxaban, Dabigatran, and Apixaban
Pharmaceutics | Free Full-Text | The Development and Optimization of Hot-Melt Extruded Amorphous Solid Dispersions Containing Rivaroxaban in Combination with Polymers
Top heart doctors fret over new blood thinners | Fox News
PDF) QUANTIFICATION OF ANTICOAGULANTS DABIGATRAN, RIVAROXABAN, AND PRASUGREL BY CHROMATOGRAPHIC AND SPECTROMETRIC TECHNIQUES – REVIEW
Comparative Risk of Bleeding of Anticoagulant Therapy with Vitamin K Antagonists (VKAs) and with Non-Vitamin K Antagonists in Pa
Eliquis vs. Xarelto: Differences, similarities, and which is better for you
Office of Clinical Parmacology Review (XARELTO)
Office of Clinical Parmacology Review (XARELTO)
Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study | Thrombosis Journal | Full Text
202439Orig1s000
Different Involvement of OAT in Renal Disposition of Oral Anticoagulants Rivaroxaban, Dabigatran, and Apixaban - Journal of Pharmaceutical Sciences
Therapeutic Monitoring of Rivaroxaban in Dogs Using Thromboelastography and Prothrombin Time
Office of Clinical Parmacology Review (XARELTO)
RBCP - Cost comparison between enoxaparin and new oral anticoagulants dabigatran and rivaroxaban in venous thromboembolism prophylaxis
Comparative study of boron-doped diamond, basal-plane pyrolytic graphite, and graphite flake paste electrodes for the voltammetric determination of rivaroxaban and dabigatran etexilate in pharmaceuticals and urine samples - ScienceDirect
Insight: Top heart doctors fret over new blood thinners | Reuters
Trends in utilization, reimbursement, and price for DOACs and warfarin in the US Medicaid population from 2000 to 2020 | SpringerLink
Pradaxa And Xarelto: Top Heart Doctors Concerned Over New Blood Thinners | HuffPost Life
Prescription Drugs Manufactured By Janssen Pharmaceuticals, Inc. - Recall Guide
Office of Clinical Parmacology Review (XARELTO)
Atrial fibrillation and ischemic events with rivaroxaban in patients with stable coronary artery disease (AFIRE): Protocol for a multicenter, prospective, randomized, open-label, parallel group study - ScienceDirect
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years | European Journal of Hospital Pharmacy
